ER Unfolded Protein Response in Liver In Vivo Is Characterized by Reduced, Not Increased, De Novo Lipogenesis and Cholesterol Synthesis Rates with Uptake of Fatty Acids from Adipose Tissue: Integrated Gene Expression, Translation Rates and Metabolic Fluxes

Int J Mol Sci. 2022 Jan 19;23(3):1073. doi: 10.3390/ijms23031073.

Abstract

The unfolded protein response in the endoplasmic reticulum (UPRER) is involved in a number of metabolic diseases. Here, we characterize UPRER-induced metabolic changes in mouse livers in vivo through metabolic labeling and mass spectrometric analysis of lipid and proteome-wide fluxes. We induced UPRER by tunicamycin administration and measured synthesis rates of proteins, fatty acids and cholesterol, as well as RNA-seq. Contrary to reports in isolated cells, hepatic de novo lipogenesis and cholesterogenesis were markedly reduced, as were mRNA levels and synthesis rates of lipogenic proteins. H&E staining showed enrichment with lipid droplets while electron microscopy revealed ER morphological changes. Interestingly, the pre-labeling of adipose tissue prior to UPRER induction resulted in the redistribution of labeled fatty acids from adipose tissue to the liver, with replacement by unlabeled glycerol in the liver acylglycerides, indicating that the liver uptake was of free fatty acids, not whole glycerolipids. The redistribution of adipose fatty acids to the liver was not explicable by altered plasma insulin, increased fatty acid levels (lipolysis) or by reduced food intake. Synthesis of most liver proteins was suppressed under UPRER conditions, with the exception of BiP, other chaperones, protein disulfide isomerases, and proteins of ribosomal biogenesis. Protein synthesis rates generally, but not always, paralleled changes in mRNA. In summary, this combined approach, linking static changes with fluxes, revealed an integrated reduction of lipid and cholesterol synthesis pathways, from gene expression to translation and metabolic flux rates, under UPRER conditions. The reduced lipogenesis does not parallel human fatty liver disease. This approach provides powerful tools to characterize metabolic processes underlying hepatic UPRER in vivo.

Keywords: ER stress; UPR; lipid metabolism; metabolism; proteostasis.

MeSH terms

  • Adipose Tissue / metabolism
  • Animals
  • Cholesterol / metabolism*
  • Fatty Acids / blood*
  • Gene Expression Profiling / methods*
  • Gene Expression Regulation / drug effects
  • Gene Regulatory Networks / drug effects*
  • Insulin / blood
  • Lipogenesis / drug effects
  • Liver / metabolism*
  • Male
  • Mass Spectrometry
  • Mice
  • Models, Animal
  • RNA-Seq
  • Tunicamycin / adverse effects*
  • Unfolded Protein Response

Substances

  • Fatty Acids
  • Insulin
  • Tunicamycin
  • Cholesterol